Application of cistanche deserticola extract and echinacoside in preparation of medicine with gastric mucosa protection effect
The invention belongs to the field of medicines, and particularly relates to application of a cistanche deserticola extract in preparation of a medicine which has a gastric mucosa protection effect and is used for preventing or treating gastric mucosal injury or gastric ulcer. Experimental results show that the cistanche extracts comprise tubulosa or desert cistanche total glycosides, tubulosa or desert cistanche polysaccharides, and tubulosa or desert cistanche oligosaccharides; according to the present invention, the compound has significant gastric mucosa protection effects on the gastric mucosa, and the monomeric compounds including salidroside, verbascoside, 2 '-acetyl verbascoside, tubuloside A, echinacoside and isoverbascoside. The application has the prospect of being developed into a medicine which has a gastric mucosa protection effect and is used for preventing or treating gastric mucosal injury and gastric ulcer, and has important clinical significance and commercial value..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 18. Aug. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
TU PENGFEI [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-08-18, Last update posted on www.tib.eu: 2023-12-05, Last updated: 2023-12-08 |
|---|
| Patentnummer: |
CN116603006 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018551181 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018551181 | ||
| 003 | DE-627 | ||
| 005 | 20231208115414.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231117s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018551181 | ||
| 035 | |a (EPA)CN116603006 | ||
| 035 | |a (EPA)87674215 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a TU PENGFEI |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of cistanche deserticola extract and echinacoside in preparation of medicine with gastric mucosa protection effect |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-08-18, Last update posted on www.tib.eu: 2023-12-05, Last updated: 2023-12-08 | ||
| 520 | |a The invention belongs to the field of medicines, and particularly relates to application of a cistanche deserticola extract in preparation of a medicine which has a gastric mucosa protection effect and is used for preventing or treating gastric mucosal injury or gastric ulcer. Experimental results show that the cistanche extracts comprise tubulosa or desert cistanche total glycosides, tubulosa or desert cistanche polysaccharides, and tubulosa or desert cistanche oligosaccharides; according to the present invention, the compound has significant gastric mucosa protection effects on the gastric mucosa, and the monomeric compounds including salidroside, verbascoside, 2 '-acetyl verbascoside, tubuloside A, echinacoside and isoverbascoside. The application has the prospect of being developed into a medicine which has a gastric mucosa protection effect and is used for preventing or treating gastric mucosal injury and gastric ulcer, and has important clinical significance and commercial value. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C07H: Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids (derivatives of aldonic or saccharic acids c07c, c07d;aldonic acids, saccharic acids c07c0059105000, c07c0059285000;cyanohydrins c07c0255160000;glycals c07d;compounds of unknown constitution c07g;polysaccharides, derivatives thereof c08b;dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification c12n0015000000;sugar industry c13) | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ZHENG JIAO |4 aut | |
| 700 | 0 | |a LI JUN |4 aut | |
| 700 | 0 | |a JIANG YONG |4 aut | |
| 700 | 0 | |a SONG YUELIN |4 aut | |
| 700 | 0 | |a ZHAO YUNFANG |4 aut | |
| 700 | 0 | |a SHI SHEPO |4 aut | |
| 700 | 0 | |a MA JIALE |4 aut | |
| 700 | 0 | |a HUO HUIXIA |4 aut | |
| 700 | 0 | |a GAO YUNJIA |4 aut | |
| 700 | 0 | |a ZHANG QIAN |4 aut | |
| 700 | 0 | |a WANG LINGXIAO |4 aut | |
| 700 | 0 | |a ZHAO YIMU |4 aut | |
| 700 | 0 | |a YIN ZIYU |4 aut | |
| 700 | 0 | |a GAO YUN |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 18. Aug. |
| 773 | 1 | 8 | |g year:2023 |g day:18 |g month:08 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/87674215/publication/CN116603006A1?q=CN116603006 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 18 |c 08 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 18 |c 08 | ||